3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
11
Gynecologic
4
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Conditions
Lung Neoplasms
10
Small Cell Lung Carcinoma
9
Mesothelioma, Malignant
7
Carcinoma, Non-Small-Cell Lung
5
Neoplasm Metastasis
4
Sarcoma
3
Thymoma
2
Ovarian Neoplasms
2
Neoplasms
2
Mesothelioma
2
Lymphoma, Non-Hodgkin
2
Head and Neck Neoplasms
2
Glioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thymic epithelial tumor
1
Stomach Neoplasms
1
Sezary Syndrome
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
pembrolizumab
39
Nivolumab
13
Cisplatin
12
Paclitaxel
11
Docetaxel
11
Carboplatin
10
atezolizumab
9
Trastuzumab
9
Gemcitabine
9
Cyclophosphamide
8
fludarabine
7
Bevacizumab
7
aldesleukin
6
durvalumab
5
Taxes
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Leucovorin
5
Irinotecan
5
Fluorouracil
5
130-nm albumin-bound paclitaxel
5
avelumab
4
Specimen Handling
4
Psychiatric Rehabilitation
4
Ipilimumab
4
Drug Therapy
4
Cetuximab
4
Capecitabine
4
Albumin-Bound Paclitaxel
4
tislelizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
Doxorubicin
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled